The pathogenic gene screening in a Chinese familial dilated cardiomyopathy pedigree from Hubei

Yongnan Lyu1, Jingjing Chen1, Hongxin Xu1

  • 1Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan 430060, China.

Gene
|November 8, 2017
PubMed

Insights

Researchers identified a novel TTN gene mutation (c.100126A>G) in a Chinese family with dilated cardiomyopathy. This finding highlights Titin

Area of Science:

  • Genetics
  • Cardiology
  • Molecular Biology

Background:

  • Dilated cardiomyopathy (DCM) is a significant cause of heart failure, often linked to genetic mutations.
  • The TTN gene, encoding the giant sarcomere protein titin, is a major contributor to DCM but is challenging to analyze due to its large size.
  • Previous studies have suggested TTN as a key gene in familial DCM, yet comprehensive analysis remains limited.

Purpose of the Study:

  • To investigate the role of TTN gene mutations in a Chinese family presenting with familial dilated cardiomyopathy.
  • To identify specific genetic variants within the TTN gene associated with DCM in the studied cohort.
  • To understand the clinical manifestation and genetic basis of DCM in this family.

Main Methods:

  • Whole-exome sequencing or targeted gene sequencing of TTN in affected and unaffected family members.
  • Polymerase chain reaction (PCR)-based sequencing of all coding exons and adjacent intronic regions of the TTN gene.
  • Segregation analysis to confirm the inheritance pattern of identified mutations within the family.

Main Results:

  • A novel missense mutation, c.100126A>G (p.Thr33376Ala), was identified in the TTN gene in two affected family members.
  • The proband (III3) exhibited decreased cardiac function and malignant arrhythmia, while his sister (III2) remained asymptomatic with normal cardiac function.
  • The identified TTN mutation was found to segregate with the disease within the family, indicating a strong genetic link.

Conclusions:

  • The TTN gene is a crucial causative gene for familial dilated cardiomyopathy.
  • The identified TTN missense mutation (c.100126A>G) is strongly associated with the development of DCM and its clinical phenotypes.
  • This study underscores the importance of comprehensive TTN gene analysis in diagnosing and understanding familial DCM.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
540
Animal Mitochondrial Genetics02:59

Animal Mitochondrial Genetics

Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
9.4K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
622
Genetic Screens02:46

Genetic Screens

Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
5.8K
Pedigree Analysis01:35

Pedigree Analysis

Overview
89.9K
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
18.7K